CREYON
Live / Applied — Fifth extension granted (statement of use) (as of 06 Feb 2026)
What this means for you
Not registered yet, but its 23 Jul 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90846010
- Mark type
- Stylized text
- Filed
- 23 Jul 2021
- Published for opposition
- 24 Jan 2023
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic preparations and therapeutics for medical use, namely, oligonucleotides; drug delivery agents consisting of compounds that facilitate delivery of a wide range of Oligonucleotide-Based Medicines; pharmaceutical preparations of Oligonucleotide-Based Medicines for gene therapy, cell therapy, personalized medicine, and precision medicine; pharmaceutical preparations of Oligonucleotide-Based Medicines for use in the treatment of genetically based diseases and rare diseases; pharmaceutical preparations of oligonucleotide therapeutics for use in the treatment of genetically based diseases, multigenic diseases, rare diseases and ultra-rare diseases
Owner
- Creyon Bio, Inc., San Diego, CA, US
- Creyon Bio, Inc., San Diego, CA, US
Prosecution history
- 06 Feb 2026 — SOU EXTENSION 5 GRANTED
- 17 Sept 2025 — SOU EXTENSION 5 FILED
- 06 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Mar 2025 — SOU EXTENSION 4 GRANTED
- 14 Mar 2025 — SOU EXTENSION 4 FILED
- 14 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Sept 2024 — SOU EXTENSION 3 GRANTED
- 06 Sept 2024 — SOU EXTENSION 3 FILED
- 06 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 12 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Mar 2024 — SOU EXTENSION 2 GRANTED
- 11 Mar 2024 — SOU EXTENSION 2 FILED